Delivery Order SPE2DB22D2206-SPE2DB24FGU81
Award Date 4/22/24
Potential Completion Date 5/13/24
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $5,523.71 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 120 tablets of the drug Bosulif 100 mg. This contract has a completion date of February 7, 2025 and was awarded on January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product Bosulif 500 mg tablets, with a ceiling value of $10,577.74 and a period of performance through May 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a delivery order with a firm fixed price of $5,704.45 for the pharmaceutical product BOSULIF 100 MG TABLET 120S. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, worth $10,955.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including...
- The U.S. Defense Logistics Agency (DLA) awarded a $12,990.43 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a variety of pharmaceutical products and medical supplies. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Through this IDC, Amerisourcebergen supplies specialty, brand name, generic,...
- This federal contract award, identified as SPE2DX15D1022|SPE2DX25FVEUA, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,335.71 firm fixed-price delivery order is for the supply of the prescription medication Bosulif 400 mg tablets. The contract has an ultimate completion date of May 22, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order is for the supply of BOSULIF 400 MG TABLET 30S, a specialty pharmaceutical product, with a performance period through December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,298.52 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which does not have a set-aside designation, is to provide a variety of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Department of Defense worldwide. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00...
- The U.S. government awarded a Delivery Order contract worth $1,669.95 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, with a period of performance through May 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,438.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. This order is part of a larger single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...